Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Its been shown to reduce self-reported fatigue in some studies, though more research is needed to confirm its effectiveness
Exenatide, a GLP-1 agonist sold under the brand names Byetta and Bydureon by AstraZeneca (LSE: AZN) as a type 2 diabetes drug, could be useful in another indication, a trial has found
This makes it suitable for a wider range of users, including those who are sensitive to stimulants or prefer a gentler, lifestyle-friendly approach to weight management
Imaging should guide, not derail, effective treatment
M., Pike, J
US$ 22.10
US$ 21.15
US$ 21.86
